GPC3-specific CAR-T cells have demonstrated the capability to eradicate GPC3-positive HCC cells in laboratory settings and GPC3-positive HCC tumor xenografts in murine models (52, 53). Here, GPC3 is linked to hepatocellular carcinoma.